HERS Protocol 4 — Hepatic Encephalopathy Recovery & Support

Wernicke's EncephalopathyThiamine Deficiency Crisis — Recognition, Urgency, and Recovery

Frequently misdiagnosed as HE — and frequently missed entirely. Early treatment is the difference between recovery and permanent damage.

← Back to main protocol
Wernicke's encephalopathy is not hepatic encephalopathy — it is a separate, thiamine-deficiency-driven neurological emergency that occurs in the same patient population and is frequently confused with HE or missed entirely. The stakes of missing it are high: untreated Wernicke's progresses to Korsakoff syndrome, a largely irreversible amnesia syndrome. This page explains the distinction, the urgency, and the recovery protocol.
🚨 This Is a Medical Emergency — Treatment Must Begin Immediately

If you suspect Wernicke's encephalopathy based on the symptoms described below — go to the emergency room. Intravenous or intramuscular thiamine is the treatment. Oral thiamine alone is insufficient in the acute phase because oral absorption is severely impaired in heavy alcohol users.

The window for full recovery is real but narrow. Wernicke's is rapidly reversible if treated early. Delayed treatment results in Korsakoff syndrome — a chronic, severe amnestic disorder with very limited reversibility. These are not equivalent outcomes. Do not wait to see if symptoms improve on their own.

What Is Wernicke's Encephalopathy?

Wernicke's encephalopathy (WE) is an acute neurological syndrome caused by severe thiamine (Vitamin B1) deficiency. Thiamine is essential for glucose metabolism in the brain — without it, neurons in specific regions begin to fail and then die. The regions most vulnerable are the thalamus, hypothalamus, mammillary bodies, and brainstem nuclei — structures governing eye movement, balance, memory, and consciousness.

Thiamine deficiency develops in heavy alcohol users for compounding reasons: poor dietary intake, impaired intestinal absorption, reduced hepatic storage, and increased metabolic demand. The liver's role is important here — reduced hepatic thiamine storage means alcohol-related liver disease and WE often coexist, which is precisely why WE is so often misdiagnosed as HE or attributed entirely to the liver disease.

The critical distinction: HE is treated by reducing ammonia. WE is treated by replacing thiamine. A patient who has both (common) needs both addressed simultaneously. Treating only one will leave the other unresolved.

Recognizing Wernicke's — The Classic Triad and What's Usually Actually Present

The classic teaching is that Wernicke's presents with a triad of three findings. In practice, fewer than 20% of confirmed WE cases have all three. Most present with only one or two — which is why it is so frequently missed.

Classic Triad
  • Ophthalmoplegia — abnormal eye movements, nystagmus, or inability to move the eyes normally
  • Ataxia — broad-based unsteady gait, difficulty walking, falling
  • Confusion / altered mental status — similar to HE in appearance
What's Usually Present
  • Confusion and cognitive impairment (present in ~80%)
  • Gait disturbance / unsteadiness (present in ~23%)
  • Eye movement abnormalities (present in ~29%)
  • All three together: <20% of cases

Wernicke's vs Hepatic Encephalopathy — Key Differences

Wernicke's Encephalopathy
  • Caused by thiamine deficiency
  • Eye movement abnormalities are a distinguishing feature
  • Gait ataxia often pronounced
  • No asterixis (hand flap)
  • Blood ammonia: usually normal
  • Treated with IV/IM thiamine — rapid improvement (hours to days)
  • Irreversible Korsakoff syndrome if missed
Hepatic Encephalopathy
  • Caused by elevated blood ammonia
  • Eye movements typically normal
  • Asterixis (hand flap) often present
  • Blood ammonia: usually elevated
  • Sleep-wake reversal common
  • Treated by reducing ammonia load
  • Reversible with appropriate management

Note: Both conditions can coexist in the same patient, and this is common in people with alcohol-related liver disease. Treating both simultaneously is appropriate when both are suspected.

The Thiamine Emergency — What to Say at the ER

If you are taking someone to the ER with suspected Wernicke's, use this language clearly:

"This patient has a history of heavy alcohol use / known liver disease and is presenting with confusion and unsteady gait. I am concerned about Wernicke's encephalopathy. They need IV or IM thiamine before any glucose administration."

The glucose-first warning matters. Giving IV glucose (dextrose) to a thiamine-deficient patient before thiamine is administered can precipitate or worsen Wernicke's — glucose metabolism depletes the last of the available thiamine. Most ER protocols now administer thiamine alongside or before glucose in at-risk patients, but explicitly flagging the concern ensures it isn't overlooked in a busy ED.

Acute Treatment (Hospital)

First-Line Treatment — IV or IM Only
Thiamine (Vitamin B1) — Parenteral
Standard: 500mg IV three times daily × 3 days, then 250mg IM daily × 5 days. Some protocols use higher doses. The specific regimen is determined by the treating team.
Intravenous and intramuscular thiamine achieve blood and brain levels that oral supplementation cannot reach in the context of impaired gut absorption. This is not optional — the evidence clearly shows that oral thiamine is insufficient for acute WE. If IV access is difficult, IM administration is an acceptable alternative with good absorption. The dramatic improvement in eye movements and consciousness that can occur within hours of IV thiamine is itself diagnostic — it confirms the thiamine deficiency was driving the symptoms.

Post-Discharge Recovery Protocol

Once the acute phase is managed in hospital with IV/IM thiamine, the transition to oral supplementation requires doses substantially higher than a standard B-complex:

Essential — High Priority
Thiamine (Vitamin B1) — High-Dose Oral
100–300mg daily standalone (not just a B-complex). Some post-WE protocols use up to 300mg three times daily in the first weeks post-discharge. Discuss target dose with the discharging provider.
Oral thiamine absorption in alcohol-use disorder is reduced to 20–30% of normal through impaired active transport mechanisms. Higher oral doses partially compensate through passive diffusion. A standard B-50 complex contains only 50mg of thiamine — insufficient as sole thiamine supplementation post-WE. A standalone thiamine tablet alongside the B-complex is required. Fat-soluble thiamine derivatives (benfotiamine, allithiamine) have better oral bioavailability than standard thiamine HCl and are worth considering for ongoing maintenance supplementation.
Strong Support
Benfotiamine (fat-soluble thiamine)
150–300mg daily, with a fat-containing meal
Benfotiamine is a synthetic fat-soluble derivative of thiamine with substantially higher oral bioavailability than standard thiamine hydrochloride. Multiple studies show superior tissue thiamine levels with benfotiamine vs equivalent doses of standard thiamine. For patients where ongoing oral supplementation is the mainstay (post-discharge), benfotiamine is a meaningful upgrade. Can be taken alongside standard thiamine.
Full B-Complex Support
B-50 Complex
Once daily with morning meal
Thiamine deficiency rarely occurs in isolation — heavy alcohol use depletes the full B vitamin spectrum. B2 (riboflavin) is required for thiamine activation. B6 and B12 deficiencies impair neurological recovery independently. A B-50 complex provides the full panel alongside the higher-dose standalone thiamine.
Neurological Recovery Support
Magnesium Glycinate
400mg (two 200mg capsules) at night
Magnesium is a required cofactor for thiamine-dependent enzymes. Thiamine repletion is partially ineffective in the presence of magnesium deficiency — the enzymes that use thiamine cannot function without it. Magnesium deficiency is near-universal in heavy alcohol users. Correcting magnesium is a prerequisite for full thiamine repletion benefit, not an optional supplement.
Neuroprotective Recovery
Acetyl-L-Carnitine (ALCAR)
2g twice daily
ALCAR supports mitochondrial function and has shown benefit for alcohol-related neuropathy and cognitive recovery. In the post-WE context, supporting neuronal energy metabolism and myelin repair during recovery is the primary rationale. ALCAR's blood-brain barrier penetration makes it relevant to central recovery as well as peripheral.
If HE Also Present
Add the full HE protocol from the main page
LOLA 18g/day + MiraLax + zinc + probiotics/Sunfiber + BCAAs
If the patient has known liver disease alongside the Wernicke's presentation, both conditions require management simultaneously. Begin the HE protocol alongside thiamine repletion. The main protocol page has full details.

If Korsakoff Syndrome Has Developed

Korsakoff syndrome (KS) is the chronic, largely irreversible amnestic state that follows untreated or inadequately treated Wernicke's. Its hallmarks are severe anterograde amnesia (inability to form new memories), retrograde amnesia, and often confabulation (filling memory gaps with invented details without deliberate intent to deceive).

It is worth knowing what Korsakoff is not:

KS is not dementia. Reasoning, language, and many intellectual functions are often preserved. The deficit is specific to memory formation and retrieval.

KS is not necessarily static. Some improvement occurs in the first year with sustained thiamine and nutritional support — particularly if thiamine is continued, alcohol is avoided, and nutritional deficits are corrected. The degree of recovery varies widely.

High-dose thiamine should be continued even in established KS — there is no benefit to stopping it, and some evidence of ongoing slow improvement in a minority of patients.

Confabulation is not lying. The patient genuinely does not know that their memory is filling in gaps. Responding with correction is generally counterproductive; redirection is more effective.

Structured environment and routine are the most evidence-supported non-pharmacological interventions for KS — predictable environments reduce the cognitive demand on a severely impaired memory system.

Daily Timing (Post-Discharge)

Morning — with a fat-containing meal
Thiamine 100–300mg standalone · Benfotiamine 150–300mg · B-50 Complex · Vitamin D3 + K2 · Zinc 25mg · (Full HE stack if liver disease also present)
Evening
ALCAR 2g · Magnesium Glycinate 400mg · (LOLA + BCAAs + casein if HE also present)
Throughout the Day
Regular meals — do not allow extended fasting · Water consistently · No alcohol — even small amounts worsen thiamine metabolism and depletion

Eye Symptom Monitoring

Eye movement improvement is the most reliable early marker of thiamine response. After IV thiamine, improvement in ophthalmoplegia typically begins within hours. Persistent or worsening eye movement abnormalities after adequate thiamine replacement suggests either an alternative diagnosis, inadequate dosing, or concurrent structural pathology — and warrants urgent neurology review.

Monitor daily in early recovery: Ask the person to follow a slowly moving finger with their eyes. Abnormal tracking — jerky, limited range, or asymmetric movement — should be documented and reported.

Gait assessment: Ask them to walk 10 feet and turn. Broad-based stance and instability are expected to improve over days to weeks with thiamine. Improvement that plateaus or reverses warrants a call.

Signs Requiring Immediate Attention

Wernicke's encephalopathy is preventable, treatable, and recoverable — if it is recognized. The barrier is almost always recognition, not treatment. A clinician who knows to look for it, and a caregiver who knows to name it in the ER, changes outcomes that would otherwise be irreversible. That knowledge belongs in the hands of families, not locked in clinical textbooks.
Key References

Sechi G & Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology, 2007.

Galvin R et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European Journal of Neurology, 2010.

Isenberg-Grzeda E et al. Wernicke encephalopathy: under-recognized and under-treated. Psychosomatics, 2012.

Ambrose ML et al. Thiamine treatment and working memory function in alcohol-dependent people. Alcohol and Alcoholism, 2001.

Strachan RW & Henderson JG. Psychiatric syndromes due to avitaminosis B12 with normal blood and marrow. Quarterly Journal of Medicine, 1965.